WaymoLeadership ChangeWaymo faced multiple operational challenges in May 2026 including…Flutter EntertainmentMa ActivityFlutter Entertainment is leveraging 2026 FIFA World Cup as…IFSProduct LaunchIFS named Customers' Choice in Gartner Voice of the…betrProduct LaunchBetr announced a 10M free spins promotion (worth $1.776M)…MiQGeographic ExpansionMiQ is expanding with Sigma, seeking to democratise data…AccuweatherLeadership ChangeSteven R. Smith, CEO of AccuWeather, named national finalist…Samsung ElectronicsLeadership ChangeSamsung union approved deal with management securing massive annual…GartnerProduct LaunchGartner forecast indicates massive enterprise adoption of task-specific AI…VirginPartnershipSeeker entered into a global distribution partnership with Virgin…Pernod RicardGeographic ExpansionPernod Ricard held press conference in Hong Kong to…RippleStrategic HiringRipple is positioning itself aggressively in the AI agent…TideProduct LaunchTide has recently launched insurance offerings as newest addition…SoftbankProduct LaunchSoftBank announced October 2026 commercial launch of 'AI Data…Australian property development sector (multiple developers)Geographic ExpansionMajor housing supply expansion approved across Australian suburbs, particularly…
MitchelLakeGlobal Executive Search
Contact →
Talent for Innovation·Est. 2001·3,000+ placements · six offices · four regions

Company signals · Biotech & Pharma

Boehringer Ingelheim

1 signal in the current window, with MitchelLake's leadership read on each.

Market context: the MitchelLake Talent Market Index reads 108.5 — Hot; Americas signal share is easing (-9.8pts).

Signals at Boehringer Ingelheim

Product Launch

Americas

Phase 3 trial data for obesity drug survodutide shows 19% discontinuation rate due to side effects, indicating potential safety/tolerability issues that may impact market launch strategy

Leadership read: May need clinical safety officers, regulatory affairs specialists to address trial findings; potentially medical affairs and communications roles to manage market expectations and physician education

primary · 2026-06-07 · context →

Nearby in the record

Invitae — Head of Talent (2019)Invitae — Head of Talent (2018)DNAnexus — Software Engineer (2016)DNAnexus — Multiple roles (Engineering and Non-Engineering) (2016)

Share: WhatsApp · X · Email